New England Immunology Associates Inc is categorized under Diagnostic Substances in Lexington, MA and active since 1977.
New England Immunology Associates Inc was established in 1977, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Diagnostic Substances business, which does work in the B2B market, and is classified as a Diagnostic Substances, under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact Charles J Mailman at the company’s single location by writing to 217 Concord Avenue, Lexington, Massachusetts MA 02421 or by phoning (781) 863-5774. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | New England Immunology Associates Inc |
| Contact Person: | Charles J Mailman |
| Address: | 217 Concord Avenue, Lexington, Massachusetts 02421 |
| Phone Number: | (781) 863-5774 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1977 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Diagnostic Substances |
| SIC Code: | 2835 |
| NAICS Code: | 325412 |
| Share This Business: |
New England Immunology Associates Inc was started in 1977 to provide professional Diagnostic Substances under the SIC code 2835 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Charles J Mailman for inquiries that concern New England Immunology Associates Inc by calling the company number (781) 863-5774, as your correspondence is most welcome. Additionally, the physical location of the single location of New England Immunology Associates Inc can be found at the coordinates 42.416271,-71.220991 as well as the street address 217 Concord Avenue in Lexington, Massachusetts 02421.
For its online presence, you may visit New England Immunology Associates Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.